Jove
Visualize
Contact Us

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Practice Relevance as the North Star: A Message From the Editor.

The primary care companion for CNS disorders·2026
Same author

Standard Versus Enhanced Measurement-Based Care Effectiveness for Depression (EMBED): Protocol for a Cluster Randomized Implementation-Effectiveness Trial.

Cureus·2025
Same author

Efficacy and safety of lemborexant in subjects with insomnia disorder receiving medications for depression or anxiety symptoms.

Neuropsychopharmacology reports·2024
Same author

A Retrospective Cross-Sectional Analysis of the Humanistic and Economic Burden of Bipolar I Disorder.

Clinical therapeutics·2024
Same author

The Humanistic and Economic Burden Associated with Major Depressive Disorder: A Retrospective Cross-Sectional Analysis.

Advances in therapy·2024
Same author

The PCC Is 25 Years Strong: A Message From the Editor.

The primary care companion for CNS disorders·2023
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 6, 2026

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
08:33

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

Published on: January 5, 2024

Recognizing and diagnosing fibromyalgia.

Larry Culpepper1

  • 1Department of Family Medicine, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.

The Journal of Clinical Psychiatry
|December 1, 2010
PubMed
Summary
This summary is machine-generated.

Fibromyalgia, a neurologic disorder affecting 2% of Americans, involves amplified pain perception. Recognizing its central pain processing nature enables effective management and improved patient function.

Related Experiment Videos

Last Updated: Jun 6, 2026

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
08:33

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

Published on: January 5, 2024

Area of Science:

  • Neurology
  • Pain Medicine
  • Patient Management

Background:

  • Fibromyalgia impacts approximately 2% of the US population, characterized by central pain processing dysfunction.
  • It causes heightened pain perception in response to non-painful stimuli, distinguishing it from healthy pain responses.

Discussion:

  • Misunderstanding fibromyalgia's neurologic basis can lead to physician-patient frustration and treatment abandonment.
  • Effective diagnosis and treatment require recognizing the specific pain patterns and underlying pathology.

Key Insights:

  • Accurate diagnosis of fibromyalgia is crucial for initiating effective therapeutic strategies.
  • Understanding fibromyalgia as a central pain disorder facilitates better patient outcomes and functional improvement.

Outlook:

  • Continued research into central pain processing mechanisms can refine fibromyalgia diagnosis and treatment.
  • Improved physician education on fibromyalgia's nature can enhance patient care and reduce frustration.